These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6369967)

  • 1. Mechanism of action of the second-generation sulfonylurea glipizide.
    Lebovitz HE; Feinglos MN
    Am J Med; 1983 Nov; 75(5B):46-54. PubMed ID: 6369967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
    Lebovitz HE
    Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety and efficacy of glipizide.
    Feinglos MN; Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):60-6. PubMed ID: 6369969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glipizide: an overview.
    Shuman CR
    Am J Med; 1983 Nov; 75(5B):55-9. PubMed ID: 6369968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glipizide treatment on various aspects of glucose, insulin, and lipid metabolism in patients with noninsulin-dependent diabetes mellitus.
    Reaven GM
    Am J Med; 1983 Nov; 75(5B):8-14. PubMed ID: 6369970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
    Lebovitz HE; Feinglos MN; Bucholtz HK; Lebovitz FL
    J Clin Endocrinol Metab; 1977 Sep; 45(3):601-4. PubMed ID: 903405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in patients with insulin independent diabetes mellitus: partial amelioration by the sulfonylurea glipizide.
    Lebovitz H; Feinglos MN
    Adv Exp Med Biol; 1979; 119():371-9. PubMed ID: 495293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus.
    Greenfield MS; Doberne L; Rosenthal M; Schulz B; Widstrom A; Reaven GM
    Diabetes; 1982 Apr; 31(4 Pt 1):307-12. PubMed ID: 6759246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of glipizide at the pancreatic and extra-pancreatic level in non-insulin dependent diabetics].
    Sánchez MS; Ordóñez AJ; Villalba MT; de la Viña S; Nash RE; Serrano M
    Rev Med Chil; 1984 Feb; 112(2):107-14. PubMed ID: 6377432
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.
    Putnam WS; Andersen DK; Jones RS; Lebovitz HE
    J Clin Invest; 1981 Apr; 67(4):1016-23. PubMed ID: 7009650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further considerations regarding insulin secretion and metabolism after glipizide treatment.
    Bonora E; Muggeo M
    Diabetes Care; 1988 Sep; 11(8):690-2. PubMed ID: 3065008
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
    Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
    Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonylurea treatment of insulin-independent diabetes mellitus.
    Feinglos MN; Lebovitz HE
    Metabolism; 1980 May; 29(5):488-94. PubMed ID: 6990184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of insulin resistance in adipose tissue of non-insulin-dependent diabetics by treatment with diet and sulphonylurea.
    Bolinder J; Ostman J; Arner P
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):85-90. PubMed ID: 3918399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia.
    Bitzén PO; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1988; 35(1):31-7. PubMed ID: 3065086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glipizide a new oral antidiabetic agent (comprehensive review)].
    Brunová E
    Vnitr Lek; 1976 Jun; 22(6):595-9. PubMed ID: 820071
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of short-term insulin therapy upon therapeutic response to glipizide.
    Schwartz SL; Fischer JS; Kipnes MS; Boyle M
    Am J Med; 1987 Sep; 83(3A):22-30. PubMed ID: 3307403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.
    Rosenstock J; Meisel A; Raskin P
    Am J Med; 1987 Sep; 83(3A):10-5. PubMed ID: 3307402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glipizide treatment does not change erythrocyte insulin receptors in non-insulin-dependent diabetics].
    Canivet B; Freychet P
    Therapie; 1985; 40(2):93-7. PubMed ID: 4002196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.